Buys
Open market- Shares
- Avg price
- Total value
Greg Keenan - SVP, Chief Medical Officer at Aurinia Pharmaceuticals Inc.
Issuer-level insider activity
- Role
- SVP, Chief Medical Officer
- Issuer symbol
- AUPH on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
Past-year transaction volume for Greg Keenan in Aurinia Pharmaceuticals Inc.
Sells
Open market- Shares
- -20,000
- Avg price
- $10.50
- Total value
- -$210,000
Net
Past year- Shares
- -20,000
- Share %
- -100%
- Total value
- -$210,000
Reported holdings for Greg Keenan in Aurinia Pharmaceuticals Inc.
Form 4 holding
SVP, Chief Medical Officer
Aurinia Pharmaceuticals Inc.
- Security class
- Common Stock
- Shares / value
- 154,449
- Estimated value
- $2,230,243
- Report date
- 06 Mar 2026
- Price
- $14.44
- Ownership
- Direct
Form 4 holding
SVP, Chief Medical Officer
Aurinia Pharmaceuticals Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 67,870
- Estimated value
- Report date
- 27 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Greg Keenan in Aurinia Pharmaceuticals Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.